Identification of N, N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymeraseCHAN, Laval; JAGADEESWAR REDDY, T; DROUIN, Alexandre et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 8, pp 1283-1285, issn 0022-2623, 3 p.Article

In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIsBETHELL, Richard C; LIE, Yolanda S; PARKIN, Neil T et al.Antiviral chemistry & chemotherapy. 2005, Vol 16, Num 5, pp 295-302, issn 0956-3202, 8 p.Article

Short Communication Phenotypic Protease Inhibitor Resistance and Cross-Resistance in the Clinic from 2006 to 2008 and Mutational Prevalences in HIV from Patients with Discordant Tipranavir and Darunavir Susceptibility PhenotypesBETHELL, Richard; SCHERER, Joseph; WITVROUW, Myriam et al.AIDS research and human retroviruses. 2012, Vol 28, Num 9, pp 819-824, issn 0889-2229, 6 p.Article

HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESYYANNOPOULOS, Constantin G; PING XU; PROULX, Melanie et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 21, pp 5333-5337, issn 0960-894X, 5 p.Article

Effects of the W153L Substitution in HIV Reverse Transcriptase on Viral Replication and Drug Resistance to Multiple Categories of Reverse Transcriptase InhibitorsXU, Hong-Tao; COLBY-GERMINARIO, Susan P; OLIVEIRA, Maureen et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4515-4526, issn 0066-4804, 12 p.Article

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: SulfonamidesCHAN, Laval; DAS, Sanjoy K; YANNOPOULOS, Constantin G et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 3, pp 793-796, issn 0960-894X, 4 p.Article

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: Tertiary amidesCHAN, Laval; PEREIRA, Oswy; ROY, Caroline et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 3, pp 797-800, issn 0960-894X, 4 p.Article

Viral Resistance in Hepatitis C Virus Genotype 1-Infected Patients Receiving the NS3 Protease Inhibitor Faldaprevir (BI 201335) in a Phase 1b Multiple-Rising-Dose StudyBERGER, Kristi L; LAGACE, Lisette; TRIKI, Ibtissem et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 10, pp 4928-4936, issn 0066-4804, 9 p.Article

Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assemblyFADER, Lee D; BETHELL, Richard; GOUDREAU, Nathalie et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 1, pp 398-404, issn 0960-894X, 7 p.Article

Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cellsDE BAAR, Michel P; DE ROOIJ, Esther R; SMOLDERS, Karlijn G. M et al.Antiviral research. 2007, Vol 76, Num 1, pp 68-74, issn 0166-3542, 7 p.Article

Apricitabine : a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infectionWAINBERG, Mark A; CAHN, Pedro; BETHELL, Richard C et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 2, pp 61-70, issn 0956-3202, 10 p.Article

Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A ProteaseWHITE, Peter W; LLINAS-BRUNET, Montse; KUKOLJ, George et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 11, pp 4611-4618, issn 0066-4804, 8 p.Article

The Liver Partition Coefficient-Corrected Inhibitory Quotient and the Pharmacokinetic-Pharmacodynamic Relationship of Directly Acting Anti-Hepatitis C Virus Agents in HumansJIANMIN DUAN; BOLGER, Gordon; KUKOLJ, George et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 10, pp 5381-5386, issn 0066-4804, 6 p.Article